SHC
Overvalued by 151.7% based on the discounted cash flow analysis.
Market cap | $3.20 Billion |
---|---|
Enterprise Value | $5.21 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.18 |
Beta | 0.0 |
Outstanding Shares | 283,070,826 |
Avg 30 Day Volume | 1,074,586 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 62.37 |
---|---|
PEG | -55.6 |
Price to Sales | 3.8 |
Price to Book Ratio | 11.4 |
Enterprise Value to Revenue | 4.96 |
Enterprise Value to EBIT | 18.83 |
Enterprise Value to Net Income | 101 |
Total Debt to Enterprise | 0.44 |
Debt to Equity | 5.19 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...